Pulmonary arterial hypertension trials in Israel

In Israel 6 Also abroad 305

6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
Where
Petah Tikva, Ramat Gan
Age
1 year to 17 years
People
42 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT05587712 · EU 2023-504861-22-00
Phase 3Taking people
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Where
Haifa, Jerusalem, Petah Tikva, Tel Aviv
Age
18 years and over
People
344 worldwide
Run by
Insmed Incorporated
See details and how to joinNCT07179380 · EU 2025-521558-40-00
Phase 3Taking people
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Where
Haifa
Age
18 years to 75 years
People
330 worldwide
Run by
Gossamer Bio USA, Inc.
See details and how to joinNCT06274801 · EU 2023-506334-75-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
Where
Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
Age
18 years to 75 years
People
344 worldwide
Run by
Insmed Incorporated
See details and how to joinNCT07481981 · EU 2026-525265-48-00
Phase 3Enrolling by invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Where
Haifa, Jerusalem, Kfar Saba, Petah Tikva, Tel Aviv
Age
18 years and over
People
1,000 worldwide
Run by
United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00
No phaseTaking people
Tele-Pulmonary Rehabilitation For Patients With Chronic Lung Diseases
Where
Ashkelon, Tel Aviv
Age
18 years and over
People
90
Run by
Tel-Aviv Sourasky Medical Center
See details and how to joinNCT07666841